Accelerate Diagnostics, Inc. (OTC:AXDXQ), which has been struggling with a significant debt burden of $66.58 million and negative EBITDA of -$31.89 million, announced Monday that it has completed the ...
TUCSON, Ariz., Sept. 30, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX), an innovator of rapid in vitro diagnostics, announced that the U.S. Food and Drug Administration (FDA) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback